Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Added a dedicated Locations section and listed Texas as a location, replacing the previous Texas Locations grouping. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:14.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T21:18:05.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The funding-status banner regarding government operations was removed; there is no change to the study details, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:44:03.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows a 'Results First Posted' date (2024-07-09) and related results reporting details for NCT03439085.
    Difference
    0.4%
    Check dated 2025-11-03T13:18:15.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:15:04.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.1%
    Check dated 2025-09-28T23:37:06.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.